Anticoagulation and antiplatelet management in gastrointestinal endoscopy: A review of current evidence

Table 24 Percutaneous endoscopic gastrostomy/percutaneous endoscopic jejunostomy insertion

Ref.	Year	Country	Study design	n	Procedure	Medication	Relative risk
Richter et al[124]	2011	United States	Retrospective	990	PEG	Aspirin (continued)	Incidence of PPB: (1) ≤ 48 h post-PEG 2.2%; (2) > 48 h post-PEG 1.7%
Singh et al[98]	2012	United States	Retrospective	1541	PEG	Aspirin (continued)	Incidence of PPB 3.9%
Lozoya-González et al[99]	2012	Mexico	Retrospective	27	PEG	Aspirin (ceased 1-3 d before)	No incidence of PPB
Lee et al[123]	2013	South Korea	Retrospective	151	PEG	Aspirin (continued)	No incidence of PPB

PEG: Percutaneous endoscopic gastrostomy; PPB: Post-procedural bleeding.